EX1
This asset is not currently listed on any markets available through Pearler. The information on this page may be inaccurate or out of date.
Exopharm Limited
π¦πΊ ASX
π Overview
π Performance
π΅ Cost
π€ Advanced
π¨βπ©βπ§βπ¦ Community
π
-18.54%
Annual Growth
5 years average annual growth
π΅
$ 500
Minimum Order
Due to regulatory requirements
π
1
Pearlers Invested
Since January 2020
π Overview
Key information
π Fund Overview
Exopharm Limited
π Performance
Price History
-84.46%
1M
1Y
All Time
Graph
Table
Unsure how much or often to invest?
ποΈ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out βπ΅ Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out ββ±οΈ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out βπ΅ Costs
πΌ
N/A
Management Fee
Included in unit price, not charged by Pearler
πΈ
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
πΈ Net fee calculatorπ€ Advanced information
Technical Info
π° Price*
$0.03
*Price may be up to 24 hours old
π©βπ©βπ¦ Community Insights
How our community is investing
π Pearlers invested in EX1
0
π Total Capital Earnings
N/A
π Average investment frequency
N/A
π΅ Average investment amount
$1,991
β° Last time a customer invested in EX1
1272 days
EX1 investor breakdown
π΅ Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
πΆ Age of investors
18 - 25
26 - 34
35 - 90
π Legal gender of investors
Female
Male
Pearlers who invest in EX1 also invest in...
VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.
π Performance (5Yr p.a)
12.69%
π Share price
$141.27 AUD
π€ TECHNOLOGY
π GLOBAL
β³οΈ DIVERSIFIED
π HIGH PRICE GROWTH
Adairs Ltd. is engaged in retail operations in thef manchester and homewares. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-06-17. The firm has three vertically integrated brands, Adairs, Mocka, and Focus on Furniture. Its brands sell in-house designed products direct to customers in Australia and New Zealand. Adairs is a specialty omni-channel retailer of home furnishings in Australia and New Zealand with a national footprint of stores across various formats and an online channel. Mocka is a vertically integrated pure-play online home and living products designer and retailer operating in Australia and New Zealand. Mocka sells its own products in the home furniture and decor, kids, and baby categories. Focus on Furniture (Focus) is a vertically integrated omni-channel furniture and bedding retailer offering products through its network of stores in Australia and its online channel.
π Performance (5Yr p.a)
2.15%
π Share price
$2.88 AUD
ποΈ SOCIALLY AWARE
π° HIGH DIVIDEND
ποΈ CONSUMER
Kogan.com Ltd. engages in the business of a portfolio of retail and services. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2016-07-07. The Companyβs businesses include Kogan Retail, Kogan Marketplace, Kogan Mobile, Kogan Internet, Kogan Insurance, Kogan Money, Kogan Energy, Kogan Travel, Dick Smith, Matt Blatt, Mighty Ape and Brosa. Its segments include Kogan.com and Mighty Ape. Kogan.com segment is an online retailer selling in-house and third-party brand household and consumer electronics products, as well as providing services for telecommunication, Internet, insurance, home finances, utilities, vehicles and travel. The Mighty Ape segment is an online specialist retailer of gaming and entertainment products. Its offering comprises products released under Kogan.comβs brands, such as Kogan, Ovela, Fortis, Certa and Komodo, and products sourced from imported and domestic third party brands such as Apple, Canon, Swann, and Samsung. The company trades through various channels, including the Kogan.com Website and Apps and the Dick Smith Website.
π Performance (5Yr p.a)
-1.72%
π Share price
$4.56 AUD
ποΈ CONSUMER
Lovisa Holdings Ltd. engages in the retail sale of fashion jewelry and accessories. The company is headquartered in Hawthorn, Victoria. The company went IPO on 2014-12-18. The firm and its subsidiaries are primarily involved in the retail sale of fashion jewelry and accessories. The firm is also focused on designing, developing, sourcing, and merchandising all its branded products. The firm develops, designs, sources and merchandises 100% of its Lovisa branded products. The company offers a range of products, including earrings, necklaces, rings, body jewelry, and others. The company offers a range of accessories, including hair clips, watches, jewelry boxes, belts, headbands, and others. The firm has over 700 stores across over 30 countries globally, including Australia, New Zealand, Singapore, Malaysia, Hong Kong, Namibia, South Africa, France, Austria, Belgium, Germany, Luxembourg, Netherlands, Poland, Italy, Hungary, Romania, and Switzerland, Canada, Mexico, the United States, the United Kingdom, and franchised stores in the Middle East and South America.
π Performance (5Yr p.a)
29.79%
π Share price
$27.81 AUD
π HIGH PRICE GROWTH
ποΈ CONSUMER
ESGI.AX was created on 2018-03-06 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The Fund aims to provide investment returns before fees and other costs which track the performance of its Reference Index in Australian dollars.
π Performance (5Yr p.a)
8.11%
π Share price
$36.79 AUD
π€ TECHNOLOGY
π HIGH PRICE GROWTH
π GLOBAL
Want more shares? Try these...
EX1DA
Exopharm Ltd. engages in the development and commercialization of exosomes as therapeutic agents. The company is headquartered in Melbourne, Victoria. The company went IPO on 2018-12-18. The firm invests in biopharmaceutical drug development. The firm is engaged in exosome technology and holds a portfolio of intellectual property and know-how related to exosomes and the manufacture of exosomes. The Companyβs exosome technologies solve needs for the success of exosome medicines, LEAP manufacturing technology, LOAD API loading technologies and EVPS tropism technologies. The firm is making its proprietary technologies available to pharmaceutical and biotechnology companies that want to harness exosome delivery for their own products.
π Performance (5Yr p.a)
-18.71%
π Share price
$0.03 AUD
𧬠BIOTECHNOLOGY